32 results about "VITAMIN C INJECTION" patented technology

The invention discloses a mesenchymal stem cell self-preserving liquid which is prepared from the following raw materials according to volume ratios: 1-6% of self platelet lysate, 95-97% of solution medium and 0-1% of vitamin C injection, wherein the solution medium is a mixed sugar electrolyte injection or physiological saline injection. The mesenchymal stem cell self-preserving liquid has the advantages that: growth factors contained in the mesenchymal stem cell self-preserving liquid can maintain the activity state of cells, the vitamin C can maintain the activity of various peroxidases, at the same time, the mixed sugar electrolyte injection is especially suitable for cell preservation, and osmotic pressure is also favorable for nutrient absorption of the cells so as to carry out metabolism; the activity of the mesenchymal stem cells which are preserved in the mesenchymal stem cell self-preserving liquid within 8 hours is still larger than 90%, the cell activity change is not larger than 7%, and the activity of the mesenchymal stem cells which are preserved in the mesenchymal stem cell self-preserving liquid within 12 hours is still maintained at 85%; and by using the mesenchymal stem cell self-preserving liquid, the requirements for human intravenous back-transfusion safety can be met, and the cell preserving problem of long-time transport is solved, thus more patients have opportunity to undergo mesenchymal stem cell treatment.

The invention relates to the field of medical cosmetology, in particular to a permeate used in the water separation process in fat cells and a preparation method thereof. A permeate used in the process of water separation in fat cells. The permeate used in the process of water separation in fat cells mainly includes the following components in parts by volume: 40-60 parts of 45-55% glucose aqueous solution, 1.5- 4 parts of vitamin C injection and 1.5-4 parts of gentamicin injection. 45-55% glucose aqueous solution forms hypertonic fluid, vitamin C injection protects cells from being oxidized, and gentamicin injection inhibits bacterial protein synthesis. The osmotic fluid used in the water separation process in the fat cells provided by the embodiments of the present invention separates the water in the cells through osmotic pressure without damaging the cell membrane.

The invention relates to a method for preparing a technetium (99mTc) methylene diphosphonate injection medicament with long effective period. The method specifically comprises the following steps: diluting a vitamin C injection by 20-200 times according to the requirements; pumping 10-200mCi of high-technetium (99mTc) acid sodium injection and diluting to 4ml; taking a stannous methylene diphosphonate lyophilized product for injection out of a refrigerator and placing into room temperature; injecting the high-technetium (99mTc) acid sodium injection into the stannous methylene diphosphonate lyophilized product once, shaking, fully dissolving, standing for 5min and obtaining the technetium (99mTc) methylene diphosphonate injection; and pumping 0.1ml of the well diluted vitamin C injection by using a disposable sterile syringe, injecting into the well prepared technetium (99mTc) methylene diphosphonate injection and uniformly shaking. Compared with the prior art, the prepared technetium (99mTc) methylene diphosphonate injection medicament has the advantages of long effective period, no decomposition in transportation process, relatively good imaging effect and the like.

The invention discloses a vitamin C injection and a preparation method thereof. The formula consists of: vitamin C 5.000Kg, sodium bicarbonate 2.498-2.502Kg, sodium metabisulfite 39.970-40.020g, L-cysteine ​​hydrochloride 39.980-40.020g , sodium dithionite 39.980~40.010g, thioglycerol 29.990~30.020g, calcium sodium edetate 9.990~10.010g, 59.960~60.010g activated carbon for 767-type injection, add water for injection to 20L, and disclose its preparation method. Using the new formula of sodium metabisulfite, L-cysteine ​​hydrochloride, sodium dithionite, and thioglycerol in combination with four antioxidants, it effectively improves the antioxidant activity of vitamin C, reduces the impurity content, and the appearance of the product changes from the usual The yellowish clear liquid changed into a colorless clear liquid.

The invention discloses a vitamin C sodium squirt cut for injection and a preparation method, and the invention belongs to the field of the medical industry, and the invention relates to a vitamin squirt cut for injection and a preparation method, in particular discloses a vitamin C sodium squirt cut. The vitamin C sodium squirt cut comprises the vitamin C sodium, the anti-oxidant, the anti-oxygensynergistic agent and the water for the injection. The preparation method comprises three procedures which are the preparing of liquid medicine, the removing of the origin of heat and the split charging. Compared with the listed vitamin C sodium preparations, the vitamin C sodium squirt cut has the advantages of low cost and good stability, and the invention can be widely applied in the field ofthe medical industry.

The invention provides a method used for increasing a reporting rate of adverse drug reactions of clinical drugs, and belongs to the technical field of medical systems. According to the method, an adverse drug reaction (ADR) case is monitored through reverse screening, and a data terminal used for the ADR case processes compatibility of uploaded drugs, eliminates a nidus time limit and determines a check image of the ADR case, so that the technical effect of improving the effect of dexamethasone injection, vitamin C injection, calcium gluconate injection and loratadine tablets for the ADR case is achieved, and the technical problems of ADR and the like caused by unreasonable drug compatibility of the clinical drugs are avoided; and by use of the method provided by the invention, the working efficiency can be improved, the ADR reporting work of medical personnel can be effectively guided and supervised, and the phenomena of non-reporting and underreporting are greatly reduced, so that the method is worthy of nationwide popularization.

The present invention discloses a Qianliexian Weisuokangyan injection for effectively curing hyperplasia of prostate and prostatic hypertrophy with chronic prostatitis. It is made up by mixing 25% (g.wt / 100ml) sorbitol injection 4 ml, 10% vitamin C injection 2 ml, 1% L-ofloxacin injection 2 ml and 2% lidocaine injection 2 ml.